Alkem Labs gets 4 observations from USFDA for St. Louis facility

The Company's manufacturing facility located at St. Louis, Fenton Logistics Park, US, was inspected from 16th August, 2019, to 22nd August, 2019.

Sep 12, 2019 03:09 IST India Infoline News Service

Pharma company Alkem Laboratories on Wednesday announced the closure of USFDA's inspection at its St. Louis facility in the US. 

The company said, "..,this is to inform you that USFDA has issued an Establishment Inspection Report (EIR) for the Company's manufacturing facility located at St. Louis, Fenton Logistics Park, USA which was inspected from 16th August, 2019 to 22nd August, 2019 and where the Company received a Form 483 issued by the USFDA containing four observations."

The inspection has now been closed by the USFDA, the company added.

Alkem Laboratories Ltd ended at Rs1,848.50 up by Rs48.15 or 2.67% from its previous closing of Rs1,800.35 on the BSE.
The scrip opened at Rs1,844.95 and touched a high and low of Rs1,852.20 and Rs1,770 respectively. A total of 1,12,570 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs22,101.59cr.




Related Story